| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 03/06/2013 | CN102952146A Heterocyclic compound, organic light-emitting device, and flat display device |
| 03/06/2013 | CN102952139A Trans-3a-fluoropyrrolidine[3,4-C]benzo cyclocompound and preparation method thereof |
| 03/06/2013 | CN102952064A Preparation method of medicine intermediate cis-ex-bicyclo[2.2.1]heptane-2.3-dicarboximide |
| 03/06/2013 | CN102952063A Synthesis method for cyclopentane-1,2-dicarboximide |
| 03/06/2013 | CN102952062A Substituted benzoheterocyclic compounds and preparation method and application thereof |
| 03/06/2013 | CN102952061A N-substituted indole-diketone compound and preparation method thereof |
| 03/06/2013 | CN102952060A Preparation method of feed additive tryptophane copper complex |
| 03/06/2013 | CN102952015A Ultraviolet light monomer compound and preparation method thereof, polymerizable composition, backlight module and liquid crystal display |
| 03/06/2013 | CN101293865B Organic compound and anthracene derivative |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 03/05/2013 | US8389563 C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers |
| 03/05/2013 | US8389443 Geminal alkoxy/alkylspirocyclic substituted tetramate derivatives |
| 03/05/2013 | CA2579119C Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/28/2013 | WO2013028543A1 Bax agonist, compositions, and methods related thereto |
| 02/28/2013 | WO2013027906A1 Compound for an organic optoelectric device, organic light emitting element including same, and display device including the organic light emitting element |
| 02/28/2013 | WO2013027853A1 Ester production method |
| 02/28/2013 | WO2013027693A1 Organic electroluminescent element, compound, and light emitting device, display device and lighting system, using said element |
| 02/28/2013 | WO2013027510A1 Organic electroluminescence element and lighting system |
| 02/28/2013 | WO2013026726A1 Dihydrofuran derivatives as insecticidal compounds |
| 02/28/2013 | WO2013026724A1 Dihydrofuran derivatives as insecticidal compounds |
| 02/28/2013 | WO2012125544A3 Necroptosis inhibitors and methods of use therefor |
| 02/28/2013 | WO2011115527A8 New biologically active compound n-[3-(4-nitrophenylamino)-indol-2-ylmethylene]aminoguanidine hydrochloride with anti-inflammatory activity |
| 02/28/2013 | US20130053558 Organic compounds for electroluminescent devices |
| 02/28/2013 | US20130053377 Inhibitors of beta-secretase |
| 02/28/2013 | US20130053315 Novel glp-1 derivatives |
| 02/28/2013 | US20130052138 Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| 02/28/2013 | US20130052130 Branched Discreet PEG Constructs |
| 02/28/2013 | US20130048975 Phenanthrocarbazole compound, and organic electroluminescent device using same |
| 02/28/2013 | CA2848726A1 Bax agonist, compositions, and methods related thereto |
| 02/27/2013 | EP2560954A2 Process of producing cycloalkylcarboxamido-indole compounds |
| 02/27/2013 | EP2560953A2 Novel inhibitors |
| 02/27/2013 | EP2560634A1 Nitric oxide releasing prodrugs of therapeutic agents |
| 02/27/2013 | CN102947964A Use of substituted perylenes in organic solar cells |
| 02/27/2013 | CN102947268A Indolyl or indolinyl hydroxamate compounds |
| 02/27/2013 | CN102942516A Alkaloid compound and preparation method and application of alkaloid compound |
| 02/27/2013 | CN102942515A Ethane bridged indole compound, synthetic method and application thereof |
| 02/27/2013 | CN102942482A Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 02/27/2013 | CN102153515B N,N'-bis-substituted urea Raf kinase inhibitors and preparation method and application thereof |
| 02/27/2013 | CN101759628B Ethynylindole compounds |
| 02/26/2013 | US8383662 Bicyclic heteroaryl compounds |
| 02/21/2013 | WO2013024730A1 Organic electroluminescent element, compound for organic electroluminescent element, and light-emitting device, display device, and illumination device using said element |
| 02/21/2013 | WO2013024363A1 Biorenewable biodegradable surfactants |
| 02/21/2013 | US20130045930 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/21/2013 | US20130045929 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/21/2013 | US20130043460 Carbazole serial compounds |
| 02/20/2013 | EP2558447A1 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
| 02/20/2013 | EP2558446A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 02/20/2013 | CN102939674A 有机场致发光元件 Organic electroluminescent element |
| 02/20/2013 | CN102939282A Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 02/20/2013 | CN102936219A Chiral 6, 6'-2 carbazole base binaphthol |
| 02/20/2013 | CN102435588B Iodide ion sensing material and its application in iodide ion fluorescence and chromogenic detection |
| 02/20/2013 | CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof |
| 02/19/2013 | US8378339 Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods |
| 02/19/2013 | US8378120 Method and reagent for measuring nitroreductase enzyme activity |
| 02/19/2013 | US8378119 Method for producing asymmetric tetrasubstituted carbon atom-containing compound |
| 02/19/2013 | US8377456 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 02/14/2013 | WO2013022047A1 Cyclopropaneamine compound |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130040998 Fluorinated hdac inhibitors and uses thereof |
| 02/14/2013 | US20130040977 Pro-Neurogenic Compounds |
| 02/14/2013 | US20130040935 Cyclic keto-enols for therapy |
| 02/14/2013 | US20130040884 Albumin-binding conjugates comprising fatty-acid and peg |
| 02/14/2013 | US20130040389 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex |
| 02/14/2013 | US20130039854 Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer |
| 02/14/2013 | US20130037782 Heterocyclic compound and organic light-emitting diode including the same |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/13/2013 | EP2555617A1 Novel hypoglycemic compounds |
| 02/13/2013 | CN102933531A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/13/2013 | CN102933530A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/13/2013 | CN102925139A Organic light-emitting material with excellent performance and preparation method thereof |
| 02/13/2013 | CN102924461A Ternary electric memory material of azo chromophore of imide framework, as well as preparation and application of ternary electric memory material |
| 02/13/2013 | CN102924367A Benzanthracene organic light-emitting material and preparation method thereof |
| 02/13/2013 | CN102924366A Carbazole ketone intermediate containing multi-functional group structure and preparation method for carbazole ketone intermediate |
| 02/13/2013 | CN102924365A 2,7-bis(N-para-substituted phenyl)carbazole-triphenylene compounds and synthetic method thereof |
| 02/13/2013 | CN102924364A Heterocyclic compound and organic light-emitting diode comprising the same |
| 02/13/2013 | CN102924363A Crystal forms of saxagliptin and processes for preparing same |
| 02/13/2013 | CN102924362A Preparation method of hexahydro-2-cyclopentyl-pyrryl amine hydrochloride |
| 02/13/2013 | CN102924361A Synthetic method for N,N-Ethylene-Bis(bromophthalimide) |
| 02/13/2013 | CN102924360A Method for asymmetrically hydrogenating 3-idene substituted indolone through using chiral iridium catalyst |
| 02/13/2013 | CN102924359A Method for synthesizing substituted indole compounds through one-pot method |
| 02/13/2013 | CN102924358A N-methyl-indole-3-styrene compound synthesis method |
| 02/13/2013 | CN102924350A Pleuromutilin derivatives, and preparation method and application thereof |
| 02/13/2013 | CN102924217A Fluorene and pyrene derivatives and organic electroluminescent device using the same |
| 02/13/2013 | CN102060746B Synthesis method and intermediate of 3-(substituted dihydroisoindolinone-2-group)-2, 6-piperadinedione |
| 02/13/2013 | CN101844994B Gossypol amino-acid derivative for blocking invasion of human immunodeficiency viruses and preparation method and application thereof |
| 02/12/2013 | US8372990 Bicyclic tetrahydropyrrole compounds |
| 02/12/2013 | US8372989 Contacting a polypeptide with tryptophan or 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid to facilitate a conversion of tryptophan to indole-3-pyruvate, a conversion of 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid to 2-Hydroxy-2-(indol-3-ylmethyl)-4-aminoglutaric acid (monatin) |
| 02/12/2013 | US8372988 Crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine |
| 02/12/2013 | US8372864 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 02/12/2013 | CA2583660C Indoline compound and process for producing the same |
| 02/12/2013 | CA2498936C Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 02/07/2013 | WO2013019079A2 Composition containing 5-hydroxyindole compounds or sponge scalarispongia sp. extracts as active ingredients for prevention and treatment of cancer diseases |
| 02/07/2013 | WO2013017600A1 Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one |
| 02/07/2013 | WO2012111579A9 Light-emitting element |
| 02/07/2013 | WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use |
| 02/07/2013 | US20130035364 Benzylidene-indolinone compounds and their medical use |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | US20130032787 Heterocyclic compound and organic light-emitting device including the same |